Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Originally developed to treat Type 2 diabetes, researchers discovered that it also led to significant weight loss in many patients
Weve seen a 65% increase in patients seeking advanced pharmacological support at our centers since the widespread adoption of GLP-1 therapies began in early 2023
The Lancet Diabetes & Endocrinology, 7(7), 528-539
Recently, research on GLP-1 RAs mainly focus on the field of obesity
Oxid Med Cell Long [Internet] [accessed 5 Mar 18] Available at Ma Q
1 Abstract submission deadline Au 31 Pre-conference workshop proposal submission deadline Sept
US$ 25.82
US$ 24.05
US$ 29.83
US$ 27.74
US$ 29.31
US$ 22.78
US$ 26.77
US$ 27.31
US$ 21.45
US$ 22.97
US$ 26.94
